Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Major Shareholding Notification 2023

Nov 15, 2023

3662_mrq_2023-11-15_5a43ec88-eb7b-49c5-a4f8-a4ecede4174d.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Major shareholder disclosure in Medistim ASA by Danske Bank AS

Major shareholder disclosure in Medistim ASA by Danske Bank AS

We hereby declare that Danske Bank Group as of November 14 reached below 5% of threshold in Medistim ASA. Total aggregated holding is 873,108.00 corresponding to 4.76 % of the total voting rights.

Ownership consist of: Danske Invest Engros corresponding to 0.27%, Danske Invest corresponding to 0.42%, Kapitalforeningen Danske Invest Institutional corresponding to 1.29%, Finnish Fund corresponding to 0.38%, SICAV corresponding to 1.16% and Danske Fund Norway corresponding to 1.24%.